Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Re Joint Venture

12 Aug 2009 09:24

RNS Number : 3017X
Compagnie de Saint-Gobain
12 August 2009
 



August 12, 2009

Saint-Gobain steps up its growth in renewable energy with an increased participation in Avancis

As part of its development strategy for solar energy, Saint-Gobain is acquiring Shell's share of Avancis, a joint venture between the two companies. 

Avancis has developed highly competitive technology for thin-film CIS (Copper, Indium and Selenide) to manufacture photovoltaic modules. With an annual capacity of 20 megawatts, the company's first plant is already operating in TorgauGermany. This extremely promising technology necessitates expertise in glass coating and in glass thermal treatment, two processes belonging to the core portfolio of Saint-Gobain, a worldwide leader in flat glass for the building and automotive industries.

Saint-Gobain intends to accelerate the industrial development of Avancis.

Saint-Gobain provides a vast range of products and services in solar energy via Saint-Gobain Solar, its new entity which groups all of Saint-Gobain's solar businesses. Present across the whole value chain, Saint-Gobain Solar's strategy hinges on three independent activities: 

The making and selling of high-tech components for PV modules (special glass, performance plastics, etc.) and high-performance mirrors for solar thermal plant operators.

The production by its Avancis company of thin-film PV modules using CIS (Copper, Indium, Selenide) technology, for distributors and integrators.

The design and marketing of PV solutions for residential homes, offices, industrial installations and farm buildings.

Analyst & Investor Relations

Press Relations

Florence Triou-Teixeira +33 1 47 62 45 19

Etienne Humbert +33 1 47 62 30 49

Vivien Dardel  +33 1 47 62 44 29

Sophie Chevallon +33 1 47 62 30 48

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVEVLLBFKVBLBBX
Date   Source Headline
6th Jan 20265:00 pmRNSIntention to delist from the London Stock Exchange
5th Jan 20267:19 amRNSAcquisition
8th Dec 20257:38 amRNSSaint-Gobain cancels 4.2 million shares
1st Dec 20254:58 pmRNSDisposal
30th Oct 20255:54 pmRNS3rd Quarter Results
6th Oct 20257:40 amRNSCapital Markets Day
2nd Oct 20255:10 pmRNSDisposal
1st Oct 20255:08 pmRNSDisposal
26th Sep 20255:14 pmRNSNew plant
8th Sep 20255:12 pmRNSNew construction chemicals organization in Germany
20th Aug 20257:15 amRNSDisposal
31st Jul 20255:51 pmRNSHalf-year Report
29th Jul 20255:10 pmRNSAcquisition
8th Jul 20255:10 pmRNSDisposal
18th Jun 20255:06 pmRNSAcquisition
5th Jun 20256:11 pmRNSNew organization
5th Jun 20255:53 pmRNSAGM Statement
4th Jun 20257:17 amRNSNew plant
20th May 20255:12 pmRNSNew plant
24th Apr 20255:31 pmRNS1st Quarter Results
22nd Apr 20257:00 amRNSSaint-Gobain featured on CDP’s “Climate A List”
26th Mar 20257:00 amRNSBond issue
27th Feb 20255:45 pmRNSAnnual Financial Report
21st Feb 20257:10 amRNSAppointment
10th Feb 20257:12 amRNSAcquisition
4th Feb 20254:54 pmRNSProduction line
16th Jan 20255:41 pmRNSFacility
15th Jan 20255:26 pmRNSAcquisition
3rd Dec 20245:26 pmRNSDecrease in capital
3rd Dec 20247:04 amRNSAcquisition
2nd Dec 20245:10 pmRNSAcquisition
2nd Dec 20247:06 amRNSDisposal
28th Nov 20245:15 pmRNSGovernance
7th Nov 20247:12 amRNSAgreement
29th Oct 20245:55 pmRNS3rd Quarter Results
14th Oct 20245:07 pmRNSAcquisition
8th Oct 20247:05 amRNSAgreement
10th Sep 20245:13 pmRNSDisposal
2nd Sep 20247:06 amRNSDisposal
15th Aug 20246:14 pmRNSAcquisition
31st Jul 20246:07 pmRNSIssue of Debt
26th Jul 20247:00 amRNSHalf-year Report
9th Jul 20247:08 amRNSAcquisition
27th Jun 20247:00 amRNSAcquisition
7th Jun 20247:00 amRNSAGM Statement
3rd Jun 20245:18 pmRNSAcquisition
2nd May 20245:34 pmRNSAgreement
25th Apr 20245:16 pmRNS1st Quarter Results
3rd Apr 20245:44 pmRNSAcquisition
26th Mar 20246:01 pmRNSIssue of Debt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.